Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cipla Ltd ( (IN:CIPLA) ) has shared an announcement.
Cipla has notified stock exchanges that it has published newspaper advertisements supporting the Investor Education and Protection Fund Authority’s Second 100-Day Campaign, ‘Saksham Niveshak’. The campaign targets the company’s shareholders to help them regularize pending dividend claims and complete KYC updates, with details also made available on Cipla’s website, reinforcing its compliance and investor-servicing practices.
By participating in the ‘Saksham Niveshak’ initiative and formally alerting investors through national and regional newspapers, Cipla is aiming to improve shareholder awareness and reduce unclaimed dividends. The move underscores the company’s alignment with regulatory priorities under SEBI’s disclosure norms and may enhance trust and transparency for its investor base.
More about Cipla Ltd
Cipla Ltd is a leading Indian pharmaceutical company headquartered in Mumbai, operating in the global generics and branded medicines market. The company focuses on respiratory, anti-infective, cardiovascular and other therapeutic segments, supplying drugs to both domestic and international markets and maintaining listings in India and Luxembourg.
Average Trading Volume: 91,565
Technical Sentiment Signal: Hold
Current Market Cap: 990.9B INR
See more insights into CIPLA stock on TipRanks’ Stock Analysis page.